NPI: 1912334517 · WARRENTON, VA 20186 · General Acute Care Hospital · NPI assigned 09/27/2013
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 09/27/2013 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 49,211 | $1.37M |
| 2019 | 59,366 | $2.05M |
| 2020 | 44,332 | $1.74M |
| 2021 | 46,908 | $1.74M |
| 2022 | 46,540 | $2.01M |
| 2023 | 48,722 | $2.25M |
| 2024 | 28,780 | $1.70M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 13,894 | 11,405 | $2.31M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 12,425 | 10,859 | $2.18M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6,094 | 5,005 | $836K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 3,925 | 1,471 | $680K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 12,704 | 3,816 | $660K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,806 | 2,226 | $655K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 11,316 | 3,785 | $632K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3,595 | 3,293 | $552K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,456 | 2,152 | $542K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,340 | 2,968 | $493K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,913 | 2,405 | $488K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 5,567 | 1,848 | $394K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,479 | 1,320 | $394K |
| G0378 | Hospital observation service, per hour | 1,700 | 1,031 | $223K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2,344 | 2,090 | $197K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 816 | 724 | $175K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 723 | 557 | $116K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,958 | 1,177 | $87K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,008 | 1,658 | $83K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,475 | 3,087 | $75K |
| 59025 | Fetal non-stress test | 404 | 293 | $74K |
| 71046 | Radiologic examination, chest; 2 views | 3,079 | 2,775 | $72K |
| 80053 | Comprehensive metabolic panel | 14,296 | 11,025 | $57K |
| 80048 | Basic metabolic panel (calcium, ionized) | 9,691 | 6,995 | $52K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 851 | 829 | $52K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 95 | 87 | $45K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 447 | 406 | $44K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,686 | 512 | $43K |
| G0237 | Therapeutic procedures to increase strength or endurance of respiratory muscles, face to face, one on one, each 15 minutes (includes monitoring) | 1,132 | 754 | $42K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 139 | 118 | $41K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 157 | 152 | $36K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 492 | 468 | $36K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1,877 | 1,537 | $29K |
| 97113 | 456 | 175 | $27K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 7,969 | 6,261 | $26K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 146 | 137 | $24K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,136 | 930 | $24K |
| 97162 | 149 | 140 | $22K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 388 | 332 | $17K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 7,841 | 5,972 | $13K |
| 97116 | 449 | 173 | $13K | |
| 71045 | Radiologic examination, chest; single view | 6,736 | 5,409 | $12K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 46 | 41 | $12K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 662 | 646 | $11K |
| 83735 | 4,920 | 3,758 | $10K | |
| 85027 | 15,992 | 11,335 | $10K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1,721 | 1,491 | $10K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,439 | 1,255 | $10K |
| 80061 | Lipid panel | 1,414 | 1,263 | $9K |
| G0238 | Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring) | 1,003 | 682 | $9K |
| J3490 | Unclassified drugs | 4,110 | 1,755 | $9K |
| 81001 | 10,930 | 8,875 | $9K | |
| 76830 | Ultrasound, transvaginal | 68 | 59 | $8K |
| 74018 | 306 | 273 | $8K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 8,843 | 5,779 | $8K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 16 | 16 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7,637 | 6,072 | $8K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 60 | 42 | $7K |
| 73630 | 491 | 424 | $6K | |
| 84484 | 5,083 | 3,830 | $6K | |
| 84703 | 5,286 | 4,435 | $6K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,014 | 1,912 | $5K |
| 93971 | 47 | 40 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,152 | 1,061 | $5K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 3,554 | 2,405 | $5K |
| 73610 | 448 | 397 | $5K | |
| 93000 | 2,308 | 1,854 | $5K | |
| 73030 | 328 | 276 | $5K | |
| 87040 | 749 | 583 | $4K | |
| 85379 | 925 | 830 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,702 | 3,882 | $4K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 66 | 52 | $4K |
| 83880 | 488 | 385 | $3K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 475 | 386 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4,709 | 3,427 | $3K |
| 76642 | 28 | 27 | $3K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 12 | 12 | $3K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,306 | 1,777 | $2K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2,427 | 2,069 | $2K |
| J0690 | Injection, cefazolin sodium, 500 mg | 443 | 292 | $2K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 14 | 13 | $2K |
| 76770 | 18 | 14 | $2K | |
| 82962 | 5,998 | 3,350 | $2K | |
| 88342 | 211 | 187 | $2K | |
| 97010 | 105 | 25 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 116 | 107 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,668 | 1,526 | $2K |
| 80076 | 568 | 468 | $2K | |
| J1815 | Injection, insulin, per 5 units | 95 | 30 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 4,203 | 2,419 | $2K |
| 87070 | 2,577 | 2,256 | $2K | |
| 85610 | 3,755 | 2,729 | $2K | |
| 73564 | 119 | 102 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 839 | 736 | $1K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 31 | 12 | $1K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 15 | 14 | $1K |
| 83605 | 1,030 | 827 | $1K | |
| 73110 | 54 | 51 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 13 | 12 | $1K |
| 87186 | 1,656 | 1,381 | $1K | |
| 73130 | 64 | 55 | $1K | |
| 87400 | 193 | 180 | $1K | |
| 85730 | 2,725 | 2,137 | $968.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 5,050 | 3,518 | $891.19 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 66 | 55 | $707.23 |
| 92523 | 13 | 13 | $611.84 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,349 | 1,058 | $590.07 |
| 87077 | 1,074 | 912 | $583.55 | |
| 86850 | 382 | 304 | $566.89 | |
| 86900 | 835 | 654 | $526.05 | |
| 82607 | 96 | 84 | $523.99 | |
| 86901 | 836 | 654 | $455.80 | |
| 72110 | 13 | 13 | $449.12 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 2,816 | 1,241 | $393.67 |
| 83690 | 5,698 | 4,570 | $386.14 | |
| 84439 | 62 | 53 | $359.34 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,603 | 3,801 | $334.65 |
| 90715 | 12 | 12 | $254.50 | |
| 82746 | 43 | 39 | $226.58 | |
| 87205 | 655 | 531 | $197.69 | |
| 96376 | 2,091 | 1,289 | $161.67 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,642 | 1,511 | $142.54 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 338 | 276 | $132.24 |
| 84100 | 482 | 338 | $128.33 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,429 | 981 | $104.27 |
| 97168 | 17 | 17 | $104.27 | |
| 86140 | 101 | 70 | $102.18 | |
| 97164 | 22 | 20 | $98.74 | |
| 82728 | 13 | 12 | $94.47 | |
| 85652 | 130 | 91 | $93.25 | |
| 84702 | 103 | 80 | $92.17 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,115 | 603 | $76.64 |
| J2704 | Injection, propofol, 10 mg | 3,101 | 2,522 | $70.67 |
| 97597 | 25 | 12 | $68.38 | |
| J2060 | Injection, lorazepam, 2 mg | 792 | 498 | $63.75 |
| 87147 | 217 | 190 | $34.17 | |
| 82803 | 137 | 107 | $25.90 | |
| 87088 | 53 | 50 | $18.99 | |
| J1644 | Injection, heparin sodium, per 1000 units | 544 | 196 | $17.85 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 94 | 73 | $12.44 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 81 | 62 | $5.91 |
| 82043 | 15 | 13 | $5.15 | |
| 82550 | 15 | 13 | $2.91 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 16 | 14 | $2.23 |
| A9270 | Non-covered item or service | 5,552 | 1,068 | $0.40 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 126 | 106 | $0.00 |
| 36600 | 17 | 13 | $0.00 | |
| 88312 | 24 | 24 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 15 | 12 | $0.00 |
| 82375 | 17 | 13 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 76 | 26 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 19 | 14 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 20 | 14 | $0.00 |
| 99152 | 17 | 14 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 20 | 14 | $0.00 |
| C1769 | Guide wire | 101 | 86 | $0.00 |
| 87807 | 205 | 178 | $0.00 | |
| 88304 | 18 | 13 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 15 | 12 | $0.00 |
| 76801 | 12 | 12 | $0.00 |